Debt Reduction Deal Sends Microcap Soaring

Sponsored:

Friday, June 5, 2026

Balance sheet strength can be just as powerful a catalyst as revenue growth. When a heavily indebted company secures a path to dramatically reduce its liabilities while maintaining normal operations, traders often take notice.

Shares of Inotiv, Inc. (NASDAQ: NOTV) are surging Wednesday after the contract research organization announced a comprehensive recapitalization plan designed to strengthen its capital structure and position the company for future growth. The move includes commitments for $65 million in financing and support from substantially all of the company's existing lenders and junior creditors.

Inotiv specializes in nonclinical and analytical drug discovery and development services, along with research models and related products used by pharmaceutical and medical device companies. Its services support drug discovery and preclinical development programs aimed at bringing new therapies to market more efficiently.

To implement the recapitalization, Inotiv has entered into a Restructuring Support Agreement with key financial stakeholders and filed a voluntary prepackaged Chapter 11 case in the U.S. Bankruptcy Court for the Southern District of Texas. The company expects the process to move on an expedited basis and emphasized that normal business operations will continue without disruption.

A central component of the transaction is the planned reduction of approximately $326 million in debt. In addition, Inotiv has secured commitments for $25 million in new debtor in possession financing, following $40 million in bridge financing received in May. The company said these funds will support ongoing operations throughout the restructuring process.

President and Chief Executive Officer Bob Leasure said the recapitalization provides a path to strengthen the company's financial foundation while preserving its ability to serve clients and pursue long term strategic initiatives. Management expects the company to emerge from the process with significantly less debt and greater financial flexibility.

The restructuring already has broad support. Inotiv reported that it has secured affirmative votes from holders representing the necessary majorities across all tranches of its capital structure, helping pave the way for a streamlined reorganization process.

Investors appear focused on the potential for a healthier balance sheet and the company's ability to continue operating normally throughout the restructuring. The combination of substantial debt reduction, fresh capital, and lender support has placed the stock firmly on traders' radar.

Shares of NOTV are up 185.5% to $0.25 in Wednesday trading.

Sponsored: